In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. Clostridium difficile Tests are carried out to diagnose the bacterium, commonly known as C. diff, that is a major cause of serious diarrheal infections, and may also cause colon cancer. GlobalData uses proprietary data and analytics to provide a comprehensive report on the clostridium difficile tests devices market, including market shares of different players within the UK. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the clostridium difficile tests market in the UK was TECHLAB followed by SD Biosensor, bioMerieux, Danaher, DiaSorin, Thermo Fisher Scientific, Microbiologics and American Type Culture Collection.
Clostridium Difficile Tests include Clostridium Difficile Culture Tests, Clostridium Difficile Toxin Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests, Glutamate Dehydrogenase (GDH) Enzyme Immuno Assay (EIA) Tests, Clostridium Difficile Nucleic Acid Amplification Tests (NAATs) and Dual Toxin and Glutamate Dehydrogenase (GDH) Enzyme Immuno Assay (EIA) Tests.
The value of the clostridium difficile tests devices market within the UK was expected to be over $20m in 2023.
For the latest complete market share analysis of clostridium difficile tests device market in the UK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
